Literature DB >> 9155058

The influence of ifosfamide scheduling on acute nephrotoxicity in children.

M W English1, R Skinner, A D Pearson, L Price, R Wyllie, A W Craft.   

Abstract

Nephrotoxicity is a significant problem in children after treatment with ifosfamide. Acute changes in renal function were compared in 16 children receiving 9 g m(-2) of ifosfamide as a 72-h continuous infusion on one occasion and, on another course, divided into three 1-h infusions on consecutive days. Subclinical acute nephrotoxicity was demonstrated with both schedules, but there were no significant differences in severity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155058      PMCID: PMC2228242          DOI: 10.1038/bjc.1997.229

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.

Authors:  A Suarez; H McDowell; P Niaudet; E Comoy; F Flamant
Journal:  J Clin Oncol       Date:  1991-12       Impact factor: 44.544

2.  Ifosfamide, Fanconi's syndrome, and rickets.

Authors:  C B Pratt; W H Meyer; J J Jenkins; L Avery; C P McKay; R J Wyatt; M L Hancock
Journal:  J Clin Oncol       Date:  1991-08       Impact factor: 44.544

3.  Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens.

Authors:  H N Caron; N Abeling; A van Gennip; J de Kraker; P A Voûte
Journal:  Med Pediatr Oncol       Date:  1992

Review 4.  Assessment of chemotherapy-associated nephrotoxicity in children with cancer.

Authors:  R Skinner; A D Pearson; M G Coulthard; A W Skillen; A W Hodson; M E Goldfinch; I Gibb; A W Craft
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Progressive renal toxicity due to ifosfamide.

Authors:  D Heney; J Wheeldon; P Rushworth; C Chapman; I J Lewis; C C Bailey
Journal:  Arch Dis Child       Date:  1991-08       Impact factor: 3.791

6.  Ifosfamide nephrotoxicity: limited influence of metabolism and mode of administration during repeated therapy in paediatrics.

Authors:  A V Boddy; M English; A D Pearson; J R Idle; R Skinner
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

7.  Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child.

Authors:  J De Schepper; G Stevens; M Verboven; C Baeta; J Otten
Journal:  Am J Pediatr Hematol Oncol       Date:  1991

8.  Tubular function and histological findings in ifosfamide-induced renal Fanconi syndrome--a report of two cases.

Authors:  R Rossi; U Helmchen; G Schellong
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

9.  Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.

Authors:  K H Antman; L Ryan; A Elias; D Sherman; H E Grier
Journal:  J Clin Oncol       Date:  1989-01       Impact factor: 44.544

10.  The influence of age on nephrotoxicity following chemotherapy in children.

Authors:  R Skinner; A D Pearson; L Price; M G Coulthard; A W Craft
Journal:  Br J Cancer Suppl       Date:  1992-08
View more
  1 in total

Review 1.  Anticancer drug-induced kidney disorders.

Authors:  P E Kintzel
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.